Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Abiraterone | Abiraterone | 2019-10-16 | 2027-2038 | |
| Acamprosate | Acamprosate | 2013-07-16 | ||
| Acyclovir | Acyclovir | 2017-07-31 | 2027-2030 | |
| Adapalene | Adapalene | 2010-07-01 | 2024-2040 | |
| Adapalene benzoyl peroxide | Adapalene, Benzoyl peroxide | 2019-11-08 | 2024-2040 | |
| Alclometasone | Alclometasone | 2009-06-23 | ||
| Alyacen | Ethinyl estradiol, Norethindrone | 2012-01-19 | 2023-2039 | |
| Amlodipine olmesartan medoxomil | Amlodipine besylate, Olmesartan medoxomil | 2017-07-05 | — | |
| Amphetamine | Amphetamine | 2021-01-27 | 2024-2038 | |
| Aprepitant | Aprepitant | 2017-10-12 | 2027-2035 | |
| Arformoterol | Arformoterol | 2021-06-22 | ||
| Ashlyna | Ethinyl estradiol, Levonorgestrel | 2015-02-23 | 2023-2039 | |
| Aspirin dipyridamole | Aspirin, Dipyridamole | 2019-05-24 | 2023-2033 |
1
2
3
4
5
6
...
14
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use